Skin360 BIPA Class Action Settlement
Skin360 BIPA Class Action Settlement
Johnson & Johnson Consumer Inc., now known as Kenvue Brands LLC, agreed to a $4.7 million settlement over allegations that the Neutrogena Skin360 skin assessment tool violated the Illinois Biometric Information Privacy Act. Anyone who took a Skin360 skin assessment while in Illinois between December 9, 2019 and May 5, 2023, using either the mobile app or the web version, can claim a pro rata share of the fund. The claim deadline is November 25, 2026.
Settlement fund
$4.7M
Non-reversionary common fund
Top payout
Pro rata share
No documents required
Claim deadline
Nov 25, 2026
70 days remaining
You may be owed money
Filing is free and takes a few minutes. Deadline: Nov 25, 2026.
Do you qualify?
You are a Class Member if ALL of the following apply:
- You performed a Skin360 skin assessment using any version of Skin360, on the mobile app or the web application.
- You were physically in Illinois when you did it.
- The assessment took place between December 9, 2019 and May 5, 2023.
- No receipts, screenshots, or account records are required to submit a claim.
- Excluded: Anyone who used Skin360 only from outside Illinois, and anyone whose use falls outside the class period.
- Excluded: Anyone who excludes themselves from the settlement by the November 10, 2026 deadline.
Not sure if you qualify? Call the Settlement Administrator at 1-888-706-4337, email info@Skin360BIPASettlement.com, or visit Skin360BIPASettlement.com.
What happened
The named plaintiffs allege that Johnson & Johnson Consumer Inc., now known as Kenvue Brands LLC, violated the Illinois Biometric Information Privacy Act through the Neutrogena Skin360 skin assessment tool. BIPA requires companies that collect biometric identifiers from Illinois residents to give written notice, obtain written consent, and publish a retention and destruction schedule before collecting that data. The class covers anyone who performed a Skin360 assessment while in Illinois between December 9, 2019 and May 5, 2023, on any version of the mobile or web application.
Kenvue does not concede the merits of any of the claims and denies that it violated the law. The Court has not decided who is right. The parties agreed to settle to avoid the cost, risk, and delay of continued litigation, and Kenvue will pay $4.7 million into a non-reversionary common fund. Any funds left unclaimed after distribution go to a court-approved cy pres recipient rather than back to the defendant.
How to file a claim
-
1. Confirm you are eligible
You qualify if you performed a Skin360 skin assessment while physically in Illinois, using any version of the Skin360 mobile app or web application, at any time between December 9, 2019 and May 5, 2023.
-
2. Understand what you can receive
Every approved claimant receives an equal pro rata share of the $4.7 million fund after attorneys' fees and costs, service payments to the Class Representatives, and administration costs are deducted. Because the per-person amount depends on how many valid claims are filed, no fixed figure is available yet.
-
3. File online or by mail
Submit the Claim Form online at skin360bipasettlement.pnclassaction.com by November 25, 2026, or mail a paper Claim Form to: Skin360 BIPA Settlement, c/o Eisner Advisory Group LLC, P.O. Box 3116, Baton Rouge, LA 70821. If you did not receive a notice or need a paper form, call 1-888-706-4337 or email info@Skin360BIPASettlement.com. Notice documents and the Settlement Agreement are posted at Skin360BIPASettlement.com.
-
4. Receive your payment
Payments are issued as soon as practicable after the Effective Date, which arrives once the Court grants final approval at the December 17, 2026 Fairness Hearing and all appeals are complete. No follow-up is required once your claim is submitted.
Key dates
- Nov 10, 2026 Opt-out & objection deadline Upcoming
- Nov 25, 2026 Claim filing deadline Upcoming
- Dec 17, 2026 Final Fairness Hearing (10:00 a.m. ET, in person) Upcoming
- TBD after final approval Payments issued to claimants Pending
The Final Approval Hearing is scheduled for December 17, 2026 at 10:00 a.m. ET before the Honorable Michael A. Shipp in Courtroom 5W, United States District Court for the District of New Jersey, Trenton Division, 402 East State Street, Trenton, NJ 08608. The Court may move the hearing, so check Skin360BIPASettlement.com for updates before traveling.
Where the money is going
This is a non-reversionary common fund of $4.7 million. Attorneys' fees and costs, service payments to the four Class Representatives, and administration costs come out of the fund before the remainder is divided pro rata among approved claimants. Anything left over after distribution goes to a court-approved cy pres recipient.
All amounts listed above are pending and subject to final court approval at the Fairness Hearing. The Court may award less than the amounts requested. The "available for class members" figure is an estimate derived from the stated caps, not a number published by the administrator. Payments are pro rata, so the per-person amount depends on how many valid claims are filed.
Common questions
How much money will I receive?
There is no fixed per-person amount. Approved claimants split the $4.7 million fund pro rata, meaning in equal shares, after attorneys' fees and costs, service payments to the Class Representatives, and the costs of administering the settlement are deducted. The final figure depends on how many valid claims are filed.
Do I need to submit proof of purchase?
No documentation is required. You submit a Claim Form attesting that you performed a Skin360 skin assessment while in Illinois between December 9, 2019 and May 5, 2023. The administrator may follow up if it needs to verify your claim.
What if I didn’t receive a notice?
You can still file. The claim portal is open to anyone who meets the class definition, whether or not you received an emailed or mailed notice. If you need a paper Claim Form or have questions, call Eisner Advisory Group at 1-888-706-4337 or email info@Skin360BIPASettlement.com before the November 25, 2026 deadline.
Does staying in the class affect my right to sue later?
If you stay in the Settlement Class, you will be bound by the Court's Final Judgment and you release the BIPA claims described in the Settlement Agreement against Kenvue and the other released parties, whether or not you file a claim. To keep your right to sue separately, you must exclude yourself by November 10, 2026.
When will payments be sent out?
Payments are made as soon as practicable after the Effective Date, which is reached once the Court grants final approval at the December 17, 2026 hearing and all appeals are complete. An appeal can add a year or more.
Dapeer Law, P.A.
Consumer class action attorneys based in South Florida. We track settlements so you don’t have to.
Similar open settlements
This page is for informational purposes only and does not constitute legal advice. Dapeer Law, P.A. is not the administrator of this settlement and is not affiliated with Johnson & Johnson Consumer Inc., now known as Kenvue Brands LLC, Eisner Advisory Group LLC (the Settlement Administrator), or Class Counsel Grace E. Parasmo of Parasmo Lieberman Law, Class Counsel of Schwartz Law PLLC, and Class Counsel of Mazie Slater Katz & Freeman, LLC. The case is Melzer v. Johnson & Johnson Consumer Inc., Case No. 3:22-cv-03149-MAS-RLS, pending in the U.S. District Court for the District of New Jersey before the Honorable Michael A. Shipp. Class representatives are Helene Melzer, Christine Borovoy, Andy Sajnani, and Patricia Biewald. Kenvue denies wrongdoing. This website is attorney advertising. Past results do not guarantee future outcomes.